Hey Publius!
Have you heard of this new injectable pharmaceutical for canine arthritis called Librela?
You might want to look into it if it's offered for your pet...
Here's why:
 Manufacturer Alert:This new injectable drug, a sibling to the concerning Apoquel, is produced by Zoetis, a multi-billion dollar major pharmaceutical player. Given the shadowy side effects linked to Apoquel, it's prudent to approach this new drug's safety with skepticism.  Drug Class Insight:Similar to Apoquel, this injectable is a “maB” (monoclonal antibody), artificially crafted antibodies not native to the body. While aimed at targeting a chemical in arthritic joints, the potential risks and expenses raise significant concerns. maB Inhibition Worries:Selective targeting in drugs doesn't always go as planned. Consider the history of antibiotics and chemotherapy. Could inhibiting "canine nerve growth factor (NGF)" have broader effects, impacting the nervous system's development and function? Short-Term Safety Studies:Arthritis is a chronic ailment, yet safety studies for this drug only cover a brief period (9 months). What happens when administered long-term? The unknowns are unsettling. Lack of Human Approval:The absence of approval for human versions is a red flag. Similar drugs raised FDA concerns, causing serious bone disorders and accelerated joint destruction. Not exactly the outcomes you'd expect from a joint pain solution. Empower Yourself:If faced with the decision for your dog, be armed with knowledge. A simple "Thanks, but we'll research further before deciding" could be a wise response. Your pet's well-being deserves a cautious approach. Reach for Nature's Medicine Instead: Our EASE blend, formulated with turmeric and frankincense, which also have anti-inflammatory properties, work synergistically together to help relieve pain associated with joint health and helps aid with joint support. |
|
Hey Publius! Have you heard of this new injectable pharmaceutical for canine arthritis called Librela? You might want to look into it if it's offered for your pet... Here's why: Manufacturer Alert:This new injectable drug, a sibling to the concerning Apoquel, is produced by Zoetis, a multi-billion dollar major pharmaceutical player. Given the shadowy side effects linked to Apoquel, it's prudent to approach this new drug's safety with skepticism. Drug Class Insight:Similar to Apoquel, this injectable is a “maB” (monoclonal antibody), artificially crafted antibodies not native to the body. While aimed at targeting a chemical in arthritic joints, the potential risks and expenses raise significant concerns. maB Inhibition Worries:Selective targeting in drugs doesn't always go as planned. Consider the history of antibiotics and chemotherapy. Could inhibiting "canine nerve growth factor (NGF)" have broader effects, impacting the nervous system's development and function? Short-Term Safety Studies:Arthritis is a chronic ailment, yet safety studies for this drug only cover a brief period (9 months). What happens when administered long-term? The unknowns are unsettling. Lack of Human Approval:The absence of approval for human versions is a red flag. Similar drugs raised FDA concerns, causing serious bone disorders and accelerated joint destruction. Not exactly the outcomes you'd expect from a joint pain solution. Empower Yourself:If faced with the decision for your dog, be armed with knowledge. A simple "Thanks, but we'll research further before deciding" could be a wise response. Your pet's well-being deserves a cautious approach. Reach for Nature's Medicine Instead: Our EASE blend, formulated with turmeric and frankincense, which also have anti-inflammatory properties, work synergistically together to help relieve pain associated with joint health and helps aid with joint support. |
|
|
|
|
